Evelo Biosciences, Inc. EVLO
Set alert
0.00 USD 0.00 0.00%
At close · Nov 2
0.0005 Day range 0.0005
0.0001 52-week range 0.0005
- YTD
- -80.00%
- 1 year
- -80.00%
- Open
- 0.0005
- Prev close
- 0.0001
- Mkt cap
- 1.90K
- Vol
- 133
- Avg vol
- 2.65K
- EPS
- -3.14
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0005
- High
- 0.0005
- Forward P/E
- -0.03
- Beta
- 1.89
- Short ratio
- 0.12
- Inst. own
- 83.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 26, 2024
- 50-d avg
- 0.26256
- 200-d avg
- 3.43
- 1y target
- 10.00
Analyst view
Consensus: hold
Hold
Price target (mean) 10.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 1
- 2 months ago 3
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.97 | -0.97 – -0.97 | -5.60 | +82.7% | 0 | 0.0% | 1 |
| Next quarter | -0.83 | -0.83 – -0.83 | -4.20 | +80.2% | 0 | 0.0% | 1 |
| Current year | -6.70 | -6.70 – -6.70 | -26.20 | +74.4% | 0 | 0.0% | 1 |
| Next year | -1.85 | -1.85 – -1.85 | -6.70 | +72.4% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 17, 2023 | TD Cowen | Downgrade | Outperform | Market Perform |
| Jul 25, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |